Living with Cerebrotendinous Xanthomatosis: Patient, Caregiver, and Expert Perspectives

Robert D. Steiner, Andrea DeBarber, Austin Larson, Bobbi Blanchard, Shawn Laurie, Neel Odedara, Hollisa Rosengrant, Rana Dutta

Research output: Contribution to journalComment/debatepeer-review

Abstract

In this article, patients with cerebrotendinous xanthomatosis (CTX) and caregivers detail their experience with lifelong symptoms, diagnosis, treatment and efficacy, and ongoing disease management. One patient and four caregivers describe the challenges associated with pursuing a correct diagnosis for years before testing confirmed a CTX diagnosis. They also detail their ongoing struggles and desire for greater access to physicians with CTX knowledge and to reliable online resources to continue their education about the disease and strategies for symptom management. The expert perspective is a direct response by three CTX researchers, including physicians who are treating patients with CTX in the United States and experts whose laboratories provide genetic and biochemical testing for CTX. They respond to many of the patient and caregiver concerns, including steps that are being taken to identify CTX earlier and provide access to confirmatory diagnostic testing sooner, and suggest the best online resources for CTX-related information and access to webinars and support groups. While the expert perspective is a direct response to the patient and caregiver authors’ CTX journeys, it should be beneficial to any patient with CTX or their caregivers.

Original languageEnglish (US)
Pages (from-to)467-475
Number of pages9
JournalAdvances in Therapy
Volume41
Issue number2
DOIs
StatePublished - Feb 2024

Keywords

  • CDCA
  • Cerebrotendinous xanthomatosis
  • Chenodeoxycholic acid
  • CTX
  • CYP27A1

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this